Zdrowie i gospodarka · 08/04/2010

FDA Seeks Public Comment on Patent Information Collection for New Drug Applications

The Food and Drug Administration (FDA) is requesting public input on the reporting requirements for patent information associated with new drug applications, amendments, and supplements, as part of its efforts to comply with the Paperwork Reduction Act of 1995.